Who is sponsoring NCT02749123?

NCT02749123 is sponsored by J.A.R. Laboratories.

What condition does NCT02749123 study?

NCT02749123 studies Back Pain, Arthritis.

What drugs are being tested in NCT02749123?

Interventions: lidocaine 5% patch, lidocaine 3.6%, menthol 1.25%, Placebo.

What is the status of NCT02749123?

NCT02749123 is currently UNKNOWN.

Last reviewed 2016-04-19 · How we verify

Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis

NCT02749123 NA UNKNOWN

A comparison of transdermal patches for efficacy, side effects and quality of life for patients with back pain and arthritis. The three arms in the trial were; prescription strength lidocaine 5%, over the counter lidocaine 3.6%, menthol 1.25% and placebo.

Details

Lead sponsor	J.A.R. Laboratories
Phase	NA
Status	UNKNOWN
Enrolment	100
Start date	2016-04
Completion	2016-05

Conditions

Back Pain
Arthritis

Interventions

lidocaine 5% patch
lidocaine 3.6%, menthol 1.25%
Placebo

Primary outcomes

Efficacy comparison of lidocaine 5% and lidocaine 3.6%, menthol 1.25% as measured by VAS numeric 0-10 pain scale — Day ten
Endpoint is a non-inferiority statistical comparison. Comparison is based off of analysis of identical questionnaires administered at baseline and day ten

Countries

United States